CTEV
CTEVHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeOperating under the Health Information Services umbrella, CTEV is a healthcare company. Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in. Valued at $398.3M, CTEV is a small-cap name in its sector. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.
Market Cap
$398.3M
Beta
0.94
P/E (TTM)
—
P/E (Fwd)
3.21
EPS (TTM)
$-17.00
EPS (Fwd)
$7.33
ROE
—
ROA
1.2%
Cash
$14.4M
Total Debt
$4.69B
Free CF
$103.0M
52W Change
-66.3%
Annual Financials
Cash vs Debt
Where CTEV stands vs its 150-day and 200-day moving averages
As of the October 13, 2026 close, CTEV finished 8.40% below its 150-day moving average ($26.56) and 8.29% below its 200-day moving average ($26.53). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CTEV overbought or oversold?
At the October 13, 2026 close, CTEV's RSI(14) was 32.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $14.4M in cash, though total debt stands at $4.69B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $103.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROA of 1.2% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $1.08B (2022) to $965.4M (2025), a 11% decline worth watching.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing CTEV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.